Christian Müller, MD

Articles by Christian Müller, MD

Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic

ByUte Klaassen, MD,Hans Jochen Wilke, MD,Christian Müller, MD,David Borquez, MD,Michael Korn, MD,Klaus Diergarten, MD,Siegfried Seeber, MD, PhD

April 1st 1997

Our phase II study results demonstrating high efficacy and low toxicity for a weekly schedule of high-dose, 24-hour infusional 5-fluorouracil(5-FU)/folinic acid (HD5-FU/FA) in intensively pretreated patients with metastatic

Latest Updated Articles

Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic
April 1st 1997

Christian Müller, MD

Articles by Christian Müller, MD

Infusional 5-FU, Folinic Acid, Paclitaxel, and Cisplatin for Metastatic

Latest Updated Articles

Trending on CancerNetwork

Personalized Cancer Vaccine/Pembrolizumab Feasible, Effective in Newly Diagnosed GBM

SC Amivantamab May Provide More Convenience in CHRYSALIS-2 Regimen

Adjuvant Giredestrant Improves Invasive DFS in ER+, HER2– Early Breast Cancer

AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma

GLP-1 Receptor Agonists May Improve Survival, Reduce irAEs in ICI-Treated Patients